Mucosal immunization of piglets with purified F18 fimbriae does not protect against F18+ Escherichia coli infection

Veterinary Immunology and Immunopathology

Volumn 120, Issue 3-4, 2007, Pages 69-79

  Verdonck, F ^a   Tiels, P ^a   van Gog, K ^a   Goddeeris, B M ^a,b   Lycke, N ^c   Clements, J ^d   Cox, E ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Enterotoxigenic and verotoxigenic Escherichia coli; F18 fimbriae; Mucosal vaccination; Pig

Indexed keywords

F18 FIMBRAE; OMEPRAZOLE; RECOMBINANT ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; ENTEROBACTER INFECTION; ESCHERICHIA COLI; F18+ STRAIN; F4+ STRAIN; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; PIGLET;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; DRUG ADMINISTRATION ROUTES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FECES; FIMBRIAE PROTEINS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SWINE; SWINE DISEASES; TIME FACTORS; TREATMENT FAILURE;

ESCHERICHIA COLI; SUIDAE;

EID: 35448933643     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2007.06.018     Document Type: Article

References (57)

1. Agren L., Lowenadler B., and Lycke N. A novel concept in mucosal adjuvanticity: the CTA1-DD adjuvant is a B cell-targeted fusion protein that incorporates the enzymatically active cholera toxin A1 subunit. Immunol. Cell. Biol. 76 3 (1998) 280-287
2. Agren L.C., Ekman L., Lowenadler B., and Lycke N.Y. Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit. J. Immunol. 158 8 (1997) 3936-3946
3. Akhiani A.A., Stensson A., Schon K., and Lycke N. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization. Scand. J. Immunol. 63 2 (2006) 97-105
4. Bakker D., Willemsen P.T., Simons L.H., van Zijderveld F.G., and de Graaf F.K. Characterization of the antigenic and adhesive properties of FaeG, the major subunit of K88 fimbriae. Mol. Microbiol. 6 2 (1992) 247-255
5. Bertschinger H.U., Bachmann M., Mettler C., Pospischil A., Schraner E.M., Stamm M., Sydler T., and Wild P. Adhesive fimbriae produced in vivo by Escherichia coli O139:K12(B):H1 associated with enterotoxaemia in pigs. Vet. Microbiol. 25 2-3 (1990) 267-281
6. Bertschinger H.U., Nief V., and Tschape H. Active oral immunization of suckling piglets to prevent colonization after weaning by enterotoxigenic Escherichia coli with fimbriae F18. Vet. Microbiol. 71 3-4 (2000) 255-267
7. Brandtzaeg P., Farstad I.N., and Haraldsen G. Regional specialization in the mucosal immune system: primed cells do not always home along the same track. Immunol. Today 20 6 (1999) 267-277
8. Burr D.H., Rollins D., Lee L.H., Pattarini D.L., Walz S.S., Tian J.H., Pace J.L., Bourgeois A.L., and Walker R.I. Prevention of disease in ferrets fed an inactivated whole cell Campylobacter jejuni vaccine. Vaccine 23 34 (2005) 4315-4321
9. Cheng D., Sun H., Xu J., and Gao S. Prevalence of fimbial colonization factors F18ab and F18ac in Escherichia coli isolates from weaned piglets with edema and/or diarrhea in China. Vet. Microbiol. 110 1-2 (2005) 35-39
10. Choi A.H., McNeal M.M., Basu M., Flint J.A., Stone S.C., Clements J.D., Bean J.A., Poe S.A., VanCott J.L., and Ward R.L. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses. Vaccine 20 27-28 (2002) 3310-3321
11. Clarke C.J., Wilson A.D., Williams N.A., and Stokes C.R. Mucosal priming of T-lymphocyte responses to fed protein antigens using cholera toxin as an adjuvant. Immunology 72 3 (1991) 323-328
12. Cox E., and Houvenaghel A. Comparison of the in vitro adhesion of K88, K99, F41 and P987 positive Escherichia coli to intestinal villi of 4- to 5-week-old pigs. Vet. Microbiol. 34 1 (1993) 7-18
13. Dell K., Koesters R., Linnebacher M., Klein C., and Gissmann L. Intranasal immunization with human papillomavirus type 16 capsomeres in the presence of non-toxic cholera toxin-based adjuvants increased vaginal immunoglobin levels. Vaccine 24 13 (2006) 2238-2247
14. Dickinson B.L., and Clements J.D. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immunol. 63 5 (1995) 1617-1623
15. Eriksson A.M., Schon K.M., and Lycke N.Y. The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues. J. Immunol. 173 5 (2004) 3310-3319
16. Fairbrother J.M., Nadeau E., and Gyles C.L. Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies. Anim. Health Res. Rev. 6 1 (2005) 17-39
17. Felder C.B., Vorlaender N., Gander B., Merkle H.P., and Bertschinger H.U. Microencapsulated enterotoxigenic Escherichia coli and detached fimbriae for peroral vaccination of pigs. Vaccine 19 7-8 (2000) 706-715
18. Foss D.L., and Murtaugh M.P. Mucosal immunogenicity and adjuvanticity of cholera toxin in swine. Vaccine 17 7-8 (1999) 788-801
19. Gerber S., Lane C., Brown D.M., Lord E., DiLorenzo M., Clements J.D., Rybicki E., Williamson A.L., and Rose R.C. Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA. J. Virol. 75 10 (2001) 4752-4760
20. Holmgren J., and Czerkinsky C. Mucosal immunity and vaccines. Nat. Med. 11 4 Suppl. (2005) S45-S53
21. Imberechts H., Deprez P., Van Driessche E., and Pohl P. Chicken egg yolk antibodies against F18ab fimbriae of Escherichia coli inhibit shedding of F18 positive E. coli by experimentally infected pigs. Vet. Microbiol. 54 3-4 (1997) 329-341
22. Imberechts H., Wild P., Charlier G., De Greve H., Lintermans P., and Pohl P. Characterization of F18 fimbrial genes fedE and fedF involved in adhesion and length of enterotoxemic Escherichia coli strain 107/86. Microb. Pathog. 21 3 (1996) 183-192
23. Jones F.R., Hall E.R., Tribble D., Savarino S.J., Cassels F.J., Porter C., Meza R., Nunez G., Espinoza N., Salazar M., Luckett R., and Scott D. The New World primate, Aotus nancymae, as a model for examining the immunogenicity of a prototype enterotoxigenic Escherichia coli subunit vaccine. Vaccine 24 18 (2006) 3786-3792
24. Jones G.W., and Rutter J.M. Role of the K88 antigen in the pathogenesis of neonatal diarrhea caused by Escherichia coli in piglets. Infect. Immunol. 6 6 (1972) 918-927
25. Kyriakis S.C., Tsiloyiannis V.K., Vlemmas J., Lekkas S., Petridou E., and Sarris K. The efficacy of enrofloxacin in-feed medication by applying different programmes for the control of post weaning oedema disease in weaned piglets. Zentralbl. Veterinarmed. B 44 9 (1997) 523-528
26. Langermann S., Mollby R., Burlein J.E., Palaszynski S.R., Auguste C.G., DeFusco A., Strouse R., Schenerman M.A., Hultgren S.J., Pinkner J.S., Winberg J., Guldevall L., Soderhall M., Ishikawa K., Normark S., and Koenig S. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J. Infect. Dis. 181 2 (2000) 774-778
27. Langermann S., Palaszynski S., Barnhart M., Auguste G., Pinkner J.S., Burlein J., Barren P., Koenig S., Leath S., Jones C.H., and Hultgren S.J. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 276 5312 (1997) 607-611
28. Levine M.M., Black R.E., Brinton Jr. C.C., Clements M.L., Fusco P., Hughes T.P., O'Donnell S., Robins-Browne R., Wood S., and Young C.R. Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man. Scand. J. Infect. Dis. Suppl. 33 (1982) 83-95
29. Lycke N. Targeted vaccine adjuvants based on modified cholera toxin. Curr. Mol. Med. 5 (2005) 591-597
30. MacLeod D.L., and Gyles C.L. Immunization of pigs with a purified Shiga-like toxin II variant toxoid. Vet. Microbiol. 29 3-4 (1991) 309-318
31. Meijerink E., Fries R., Vogeli P., Masabanda J., Wigger G., Stricker C., Neuenschwander S., Bertschinger H.U., and Stranzinger G. Two alpha(1,2) fucosyltransferase genes on porcine chromosome 6q11 are closely linked to the blood group inhibitor (S) and Escherichia coli F18 receptor (ECF18R) loci. Mamm. Genome 8 10 (1997) 736-741
32. Meijerink E., Neuenschwander S., Fries R., Dinter A., Bertschinger H.U., Stranzinger G., and Vogeli P. A DNA polymorphism influencing alpha(1,2)fucosyltransferase activity of the pig FUT1 enzyme determines susceptibility of small intestinal epithelium to Escherichia coli F18 adhesion. Immunogenetics 52 1-2 (2000) 129-136
33. Nataro J.P., and Kaper J.B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11 1 (1998) 142-201
34. + Escherichia coli by non-immune plasma powder. Vet. Microbiol. 65 1 (1999) 37-45
35. Pierre P., Denis O., Bazin H., Mbongolo Mbella E., and Vaerman J.P. Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit. Eur. J. Immunol. 22 12 (1992) 3179-3182
36. Sarrazin E., and Bertschinger H.U. Role of fimbriae F18 for actively acquired immunity against porcine enterotoxigenic Escherichia coli. Vet. Microbiol. 54 2 (1997) 133-144
37. Seo J.Y., Seong S.Y., Ahn B.Y., Kwon I.C., Chung H., and Jeong S.Y. Cross-protective immunity of mice induced by oral immunization with pneumococcal surface adhesin a encapsulated in microspheres. Infect. Immunol. 70 3 (2002) 1143-1149
38. Smeds A., Pertovaara M., Timonen T., Pohjanvirta T., Pelkonen S., and Palva A. Mapping the binding domain of the F18 fimbrial adhesin. Infect. Immunol. 71 4 (2003) 2163-2172
39. Snoeck V., Cox E., Verdonck F., Joensuu J.J., and Goddeeris B.M. Influence of porcine intestinal pH and gastric digestion on antigenicity of F4 fimbriae for oral immunization. Vet. Microbiol. 98 1 (2004) 45-53
40. Snoeck V., Huyghebaert N., Cox E., Vermeire A., Vancaeneghem S., Remon J.P., and Goddeeris B.M. Enteric-coated pellets of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic Escherichia coli infections. Vet. Immunol. Immunopathol. 96 3-4 (2003) 219-227
41. + Escherichia coli isolates. Vet. Microbiol. 110 3-4 (2005) 277-283
42. Tiels P., Verdonck F., Coddens A., Ameloot P., Goddeeris B.M., and Cox E. Monoclonal antibodies reveal a weak interaction between the F18 fimbrial adhesin FedF and the major subunit FedA. Vet. Microbiol. 119 (2007) 115-120
43. Tsiloyiannis V.K., Kyriakis S.C., Vlemmas J., and Sarris K. The effect of organic acids on the control of post-weaning oedema disease of piglets. Res. Vet. Sci. 70 3 (2001) 281-285
44. Van den Broeck W., Cox E., and Goddeeris B.M. Receptor-dependent immune responses in pigs after oral immunization with F4 fimbriae. Infect. Immunol. 67 2 (1999) 520-526
45. Van den Broeck W., Cox E., and Goddeeris B.M. Induction of immune responses in pigs following oral administration of purified F4 fimbriae. Vaccine 17 15-16 (1999) 2020-2029
46. Van den Broeck W., Cox E., and Goddeeris B.M. Receptor-specific binding of purified F4 to isolated villi. Vet. Microbiol. 68 3-4 (1999) 255-263
47. Van der Stede Y., Cox E., and Goddeeris B.M. Antigen dose modulates the immunoglobulin isotype responses of pigs against intramuscularly administered F4-fimbriae. Vet. Immunol. Immunopathol. 88 3-4 (2002) 209-216
48. Van Zaane D., and Hulst M.M. Monoclonal antibodies against porcine immunoglobulin isotypes. Vet. Immunol. Immunopathol. 16 1-2 (1987) 23-36
49. VanCott J.L., Brim T.A., Lunney J.K., and Saif L.J. Contribution of antibody-secreting cells induced in mucosal lymphoid tissues of pigs inoculated with respiratory or enteric strains of coronavirus to immunity against enteric coronavirus challenge. J. Immunol. 152 8 (1994) 3980-3990
50. Vandemaele F., Bleyen N., Abuaboud O., vanderMeer E., Jacobs A., and Goddeeris B.M. Immunization with the biologically active lectin domain of PapGII induces strong adhesion-inhibiting antibody responses but not protection against avian pathogenic Escherichia coli. Avian Pathol. 35 3 (2006) 1-12
51. Verdonck F., Cox E., van Gog K., Van der Stede Y., Duchateau L., Deprez P., and Goddeeris B.M. Different kinetic of antibody responses following infection of newly weaned pigs with an F4 enterotoxigenic Escherichia coli strain or an F18 verotoxigenic Escherichia coli strain. Vaccine 20 23-24 (2002) 2995-3004
52. + Escherichia coli in northern Belgium. Prev. Vet. Med. 60 2 (2003) 133-141
53. Verdonck F., Cox E., Van der Stede Y., and Goddeeris B.M. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response. Vaccine 22 31-32 (2004) 4291-4299
54. Verdonck F., Snoeck V., Goddeeris B.M., and Cox E. Cholera toxin improves the F4(K88)-specific immune response following oral immunization of pigs with recombinant FaeG. Vet. Immunol. Immunopathol. 103 1-2 (2005) 21-29
55. Yuan L., Geyer A., Hodgins D.C., Fan Z., Qian Y., Chang K.O., Crawford S.E., Parreno V., Ward L.A., Estes M.K., Conner M.E., and Saif L.J. Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs. J. Virol. 74 19 (2000) 8843-8853
56. Yuan L., Iosef C., Azevedo M.S., Kim Y., Qian Y., Geyer A., Nguyen T.V., Chang K.O., and Saif L.J. Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs. J. Virol. 75 19 (2001) 9229-9238
57. Zuniga A., Yokoyama H., Albicker-Rippinger P., Eggenberger E., and Bertschinger H.U. Reduced intestinal colonisation with F18-positive enterotoxigenic Escherichia coli in weaned pigs fed chicken egg antibody against the fimbriae. FEMS Immunol. Med. Microbiol. 18 3 (1997) 153-161